BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 13319156)

  • 1. A note on the metabolism of lysergic acid by Claviceps purpurea (Fries) Tulasne.
    GJERSTAD G
    J Am Pharm Assoc Am Pharm Assoc; 1956 Jun; 45(6):428-30. PubMed ID: 13319156
    [No Abstract]   [Full Text] [Related]  

  • 2. Methods of Lysergic Acid Synthesis-The Key Ergot Alkaloid.
    Jastrzębski MK; Kaczor AA; Wróbel TM
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A note on the biosynthesis of clavine alkaloids in Claviceps purpurea strain 15B.
    BRADY LR; TYLER VE
    J Am Pharm Assoc Am Pharm Assoc; 1960 May; 49():332. PubMed ID: 13849150
    [No Abstract]   [Full Text] [Related]  

  • 4. The parasitic growth of Claviceps purpurea (Fries) Tulasne on rye and its relation to alkaloid formation.
    RAMSTAD E; GJERSTAD G
    J Am Pharm Assoc Am Pharm Assoc; 1955 Dec; 44(12):741-3. PubMed ID: 13278240
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of certain chemicals on the growth and alkaloid formation of Claviceps purpurea (Fries) Tulasne in artificial culture.
    GJERSTAD G; RAMSTAD E
    J Am Pharm Assoc Am Pharm Assoc; 1955 Dec; 44(12):736-40. PubMed ID: 13278239
    [No Abstract]   [Full Text] [Related]  

  • 6. [Contributions to the quantitative study of lysergic alkaloid distribution in the sclerotia of Claviceps purpurea].
    Ioachimescu-Angelescu E; Gruia S; Bojor O
    Rev Med Chir Soc Med Nat Iasi; 1978; 82(3):499-502. PubMed ID: 16296516
    [No Abstract]   [Full Text] [Related]  

  • 7. FORMATION OF A LYSERGIC ACID DERIVATIVE DURING THE PARASITIC DEVELOPMENT OF A STRAIN OF CLAVICEPS PASPALI STEVENS AND HALL.
    BIANCHI P; CHAIN EB; MANTLE PG; TONOLO A
    Nature; 1964 Apr; 202():312-3. PubMed ID: 14167810
    [No Abstract]   [Full Text] [Related]  

  • 8. [Problems of species and strains of the ergot Claviceps purpurea Tulasne].
    KYBAL J; BREJCHA V
    Pharmazie; 1955 Dec; 10(12):752-5. PubMed ID: 13310248
    [No Abstract]   [Full Text] [Related]  

  • 9. The culture of Claviceps purpurea. II. Preliminary metabolism studies.
    PAUL AG; KELLEHER WJ; SCHWARTING AE
    J Am Pharm Assoc Am Pharm Assoc; 1954 Apr; 43(4):205-7. PubMed ID: 13151978
    [No Abstract]   [Full Text] [Related]  

  • 10. Some aspects of phosphate metabolism of Claviceps purpurea (Fr.) Tul. II. Relationship between nucleic acids synthesis and ergot alkaloid production.
    de WAART
    Can J Microbiol; 1961 Dec; 7():883-8. PubMed ID: 14004189
    [No Abstract]   [Full Text] [Related]  

  • 11. D-lysergic acid-activating enzyme from the ergot fungus Claviceps purpurea.
    Keller U; Zocher R; Krengel U; Kleinkauf H
    Biochem J; 1984 Mar; 218(3):857-62. PubMed ID: 6326747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhodococcus erythropolis MTHt3 biotransforms ergopeptines to lysergic acid.
    Thamhesl M; Apfelthaler E; Schwartz-Zimmermann HE; Kunz-Vekiru E; Krska R; Kneifel W; Schatzmayr G; Moll WD
    BMC Microbiol; 2015 Mar; 15():73. PubMed ID: 25887091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lysergic acid ethylamide, a new ergot drug strongly sedative effect causing psychotic states].
    SOLMS H
    Schweiz Med Wochenschr; 1953 Apr; 83(15):356-60. PubMed ID: 13076048
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preservation of Claviceps purpurea, the producer of peptide ergot alkaloids, by the method of freeze drying].
    Ustiuzhanina SV; Sarkisova MA; Gorin SE
    Antibiot Khimioter; 1991 Feb; 36(2):6-8. PubMed ID: 2025122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and analysis of the ergopeptine assembly system in the ergot fungus Claviceps purpurea.
    Correia T; Grammel N; Ortel I; Keller U; Tudzynski P
    Chem Biol; 2003 Dec; 10(12):1281-92. PubMed ID: 14700635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steric course of the N-methylation in the biosynthesis of ergot alkaloids by Claviceps purpurea.
    Gröger D; Gröger L; D'Amico D; He MX; Floss HG
    J Basic Microbiol; 1991; 31(2):121-5. PubMed ID: 1880714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ergot alkaloid gene cluster in Claviceps purpurea: extension of the cluster sequence and intra species evolution.
    Haarmann T; Machado C; Lübbe Y; Correia T; Schardl CL; Panaccione DG; Tudzynski P
    Phytochemistry; 2005 Jun; 66(11):1312-20. PubMed ID: 15904941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-lysergic acid activation and cell-free synthesis of D-lysergyl peptides in enzyme fractions from the ergot fungus Claviceps purpurea.
    Keller U; Han M; Stöffler-Meilicke M
    Biochemistry; 1988 Aug; 27(16):6164-70. PubMed ID: 2847788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of the composition of a nutrient medium on growth and synthesis of ergot alkaloids by Claviceps purpurea in the saprotrophic culture].
    Sarkisova MA; Fishman VM
    Antibiot Khimioter; 1991 Dec; 36(12):8-10. PubMed ID: 1814274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ergot alkaloids. II. On the spectrum of ergot alkaloids contained in the sclerotia of Claviceps purpurea (Fr.) Tul. and Claviceps paspali Stev. et Hall.
    Kleinerová E; Kybal J
    Folia Microbiol (Praha); 1969; 14(6):602-4. PubMed ID: 5372898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.